Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metagenomic and single-cell RNA-Seq survey of the Helicobacter pylori-infected stomach in asymptomatic individuals. | JCI Insight | 2023 | 36810249 | PubTator, text mining | PubMed |
| Role of tumor microenvironment in cancer progression and therapeutic strategy. | Cancer Med | 2023 | 36807772 | PubTator, text mining | PubMed |
| Monocyte, neutrophil, and whole blood transcriptome dynamics following ischemic stroke. | BMC Med | 2023 | 36803375 | PubTator, text mining | PubMed |
| Exhaustion‑like dysfunction of T and NKT cells in an X‑linked severe combined immunodeficiency patient with maternal engraftment by single‑cell analysis. | Int J Mol Med | 2023 | 36799159 | PubTator, text mining | PubMed |
| Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies. | Front Immunol | 2023 | 36798126 | PubTator, text mining | PubMed |
A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE). | BMC Res Notes | 2023 | 36797744 | PubTator, text mining | PubMed |
| Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma. | BMC Cancer | 2023 | 36797708 | PubTator, text mining | PubMed |
| Highly Multiplexed Spatially Resolved Proteomic and Transcriptional Profiling of the Glioblastoma Microenvironment Using Archived Formalin-Fixed Paraffin-Embedded Specimens. | Mod Pathol | 2023 | 36788070 | PubTator, text mining | PubMed |
Analysis of Single-Cell Transcriptome and Surface Protein Expression in Ankylosing Spondylitis Identifies OX40-Positive and Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Positive Pathogenic Th17 Cells. | Arthritis Rheumatol | 2023 | 36787119 | PubTator, text mining | PubMed |
| Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity. | Int J Biol Sci | 2023 | 36778120 | PubTator, text mining | PubMed |
| Low-density lipoprotein balances T cell metabolism and enhances response to anti-PD-1 blockade in a HCT116 spheroid model. | Front Oncol | 2023 | 36776340 | PubTator, text mining | PubMed |
| BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma. | Front Oncol | 2023 | 36776328 | PubTator, text mining | PubMed |
| DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer. | Int J Mol Sci | 2023 | 36769317 | PubTator, text mining | PubMed |
| CD83 Regulates the Immune Responses in Inflammatory Disorders. | Int J Mol Sci | 2023 | 36769151 | PubTator, text mining | PubMed |
| Modulating Glycolysis to Improve Cancer Therapy. | Int J Mol Sci | 2023 | 36768924 | PubTator, text mining | PubMed |
| Hypoxia and Intestinal Inflammation: Common Molecular Mechanisms and Signaling Pathways. | Int J Mol Sci | 2023 | 36768744 | PubTator, text mining | PubMed |
| Comprehensive Analysis of KCNJ14 Potassium Channel as a Biomarker for Cancer Progression and Development. | Int J Mol Sci | 2023 | 36768373 | PubTator, text mining | PubMed |
| Epigenetic Perspective of Immunotherapy for Cancers. | Cells | 2023 | 36766706 | PubTator, text mining | PubMed |
| Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells. | Cancers (Basel) | 2023 | 36765558 | PubTator, text mining | PubMed |
| Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunity. | Cancer Sci | 2023 | 36762794 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=34